These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39387476)

  • 21. RETRACTION: Microrna-379 Suppresses Osteosarcoma Progression by Targeting PDK1.
    J Cell Mol Med; 2024 Aug; 28(15):e18567. PubMed ID: 39113402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3.
    J Cell Mol Med; 2024 Aug; 28(15):e18566. PubMed ID: 39109524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retraction.
    Cancer Med; 2024 Jan; 13(1):e6714. PubMed ID: 38108531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
    Mol Oncol; 2024 Aug; 18(8):2062. PubMed ID: 38873938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retraction: Wang Y, Yue D. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
    Cancer Med; 2024 Apr; 13(7):e7138. PubMed ID: 38546000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RETRACTION: High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.
    Int J Cancer; 2024 Dec; 155(11):E15. PubMed ID: 39196599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retracted: Resveratrol inhibits oesophageal adenocarcinoma cell proliferation via AMP-activated protein kinase signaling.
    Asian Pac J Cancer Prev; 2017 Nov; 18(10):2895-2895. PubMed ID: 29171745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RETRACTION: CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s.
    J Cell Physiol; 2024 Nov; 239(11):e31353. PubMed ID: 39344515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RETRACTION: MATN1-AS1 promotes glioma progression by functioning as ceRNA of miR-200b/c/429 to regulate CHD1 expression.
    Cell Prolif; 2024 Dec; 57(12):e13767. PubMed ID: 39428107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retraction statement: Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
    Mol Oncol; 2023 Aug; 17(8):1692. PubMed ID: 37471281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retraction: lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2.
    Cancer Med; 2024 Mar; 13(5):e7098. PubMed ID: 38470371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging.
    J Cell Mol Med; 2024 Aug; 28(15):e18563. PubMed ID: 39087601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retraction.
    Cancer Med; 2024 Jan; 13(1):e6713. PubMed ID: 38108614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retraction: lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR-126 to active CXCR4 and RhoA signaling pathway.
    Cancer Med; 2024 May; 13(9):e7220. PubMed ID: 38695659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retraction: Tongyi Lu, Binhua Wu, Yunfei Yu, Wenhui Zhu, Simin Zhang, Yinmei Zhang, Jiaying Guo, Ning Deng. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis. Cancer Sci. 2018; 109: 2221-2234. https://doi.org/10.1111/cas.13633.
    Cancer Sci; 2024 Apr; 115(4):1360. PubMed ID: 38342762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retraction: Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9.
    J Cell Mol Med; 2024 Apr; 28(7):e18249. PubMed ID: 38509734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.
    FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retraction: miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
    IUBMB Life; 2024 Jun; 76(6):363. PubMed ID: 38484124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation.
    Cancer Sci; 2024 Nov; 115(11):3829. PubMed ID: 39166827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retraction: Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC (2014) Up-regulation of p21
    FEBS Lett; 2024 Jun; 598(11):1449. PubMed ID: 38747074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.